Due to the heightened risk associated with COVID-19, most of our research studies are currently on hold. We will resume study enrollments and participation in new studies as soon as we are able to do so.
Believe they have suspected or is symptomatic for Urinary Tract Infection (UTI).
Are willing to take investigative medications to treat their UTI (Study sponsored by GlaxoSmithKline Research)
Are willing to sign consents to participate in the study.
Are willing to participate in the study for a duration of approximately 28 days with 4 scheduled study visits.
Are of childbearing potential (WOCBP) and is not pregnant
Are willing to abstain from sexual activity for up to 2 weeks
Are willing to be paid at each scheduled study visit (summing up to $398 at end of study participation).
This Phase III study’s aim is to evaluate the therapeutic response and clinical efficacy of oral gepotidacin compared to oral nitrofurantoin for acute cystitis(UTI) in adolescent and adult female participants.
Objective: To evaluate a vaginal gel in the prevention of urogenital CT and GC infections.
Eligibility: Healthy female subject at least 18 years of age who has been treated for a previous urogenital CT and/or GC infection within the 16 weeks and or has
documentation of infection (e.g. Laboratory report(s) confirming CT and/or GC infection or in their medical records).
Agree to use a woman-controlled method of contraception that is not directly delivered to the vaginal mucosa (with the exception of a vaginal ring) throughout the duration of the study, such as oral contraceptives, birth control implants, intrauterine devices (IUDs), or tubal ligation. Condom use only is not an acceptable form of contraception for this study.
Able and willing to comply with all study procedures, including the use of eDiaries.
8. Reports vaginal sexual intercourse with a male partner at least three times per month in the previous month and anticipates vaginal sexual intercourse regularly for the duration of the study.
Agree to abstain from douching or any form of vaginal suppository use (other than investigational product) during course of study.
Paid research - upward of $900 over 20 weeks (5 study follow-up visits).